We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$562M
AUM Growth
+$227M
Cap. Flow
+$212M
Cap. Flow %
37.82%
Top 10 Hldgs %
51.62%
Holding
194
New
19
Increased
129
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$22.2M
2
ETP
Energy Transfer Partners L.p.
ETP
+$22M
3
BPL
Buckeye Partners, L.P.
BPL
+$16.4M
4
ET icon
Energy Transfer Partners
ET
+$16.2M
5
WPZ
Williams Partners L.P.
WPZ
+$13.7M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.3M
2
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$2.47M
3
IDU icon
iShares US Utilities ETF
IDU
+$2.2M
4
IYE icon
iShares US Energy ETF
IYE
+$2.06M
5
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$1.95M

Sector Composition

Rank Sector Weight
1 Energy 69.83%
2 Healthcare 9.07%
3 Utilities 2.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRE icon
51
Sempra
SRE
$60.8B
$1.19M 0.21%
21,506
– –
CWB icon
52
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$1.16M 0.21%
24,056
+3,397
+16% +$161K
PCG icon
53
PG&E
PCG
$47.8B
$1.15M 0.2%
17,295
– –
EIX icon
54
Edison International
EIX
$30.7B
$1.14M 0.2%
14,275
– –
KERX
55
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.13M 0.2%
183,907
+17,684
+11% +$96.9K
IRWD icon
56
Ironwood Pharmaceuticals
IRWD
$611M
$1.13M 0.2%
78,995
+7,596
+11% +$104K
ICPT
57
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.12M 0.2%
9,925
+954
+11% +$111K
VIG icon
58
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.12M 0.2%
12,404
-1,084
-8% -$96.1K
CELG
59
DELISTED
Celgene Corp
CELG
$1.11M 0.2%
8,940
+859
+11% +$103K
PGNX
60
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.09M 0.19%
115,300
+11,087
+11% +$111K
BMRN icon
61
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.06M 0.19%
12,098
+1,163
+11% +$103K
REGN icon
62
Regeneron Pharmaceuticals
REGN
$68.8B
$1.05M 0.19%
2,714
+261
+11% +$96.7K
ACOR
63
DELISTED
Acorda Therapeutics
ACOR
$1.05M 0.19%
417
+40
+11% +$115K
SGEN
64
DELISTED
Seagen Inc. Common Stock
SGEN
$1.03M 0.18%
16,461
+1,583
+11% +$98.8K
SRPT icon
65
Sarepta Therapeutics
SRPT
$1.66B
$1.02M 0.18%
34,536
+3,321
+11% +$103K
LGND icon
66
Ligand Pharmaceuticals
LGND
$6.02B
$1.02M 0.18%
15,456
+1,487
+11% +$97.8K
UTHR icon
67
United Therapeutics
UTHR
$26.3B
$1.01M 0.18%
7,498
+721
+11% +$109K
ENTA icon
68
Enanta Pharmaceuticals
ENTA
$372M
$1M 0.18%
32,521
+3,127
+11% +$97.4K
BIIB icon
69
Biogen
BIIB
$29.9B
$989K 0.18%
3,617
+348
+11% +$98.4K
MNTA
70
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$970K 0.17%
72,660
+6,987
+11% +$109K
SDY icon
71
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$956K 0.17%
10,844
-10,388
-49% -$908K
TVTX icon
72
Travere Therapeutics
TVTX
$5.33B
$953K 0.17%
51,617
+4,963
+11% +$97.1K
GILD icon
73
Gilead Sciences
GILD
$161B
$929K 0.17%
13,676
+1,315
+11% +$92.5K
VNDA icon
74
Vanda Pharmaceuticals
VNDA
$312M
$906K 0.16%
64,713
+6,223
+11% +$88.7K
IONS icon
75
Ionis Pharmaceuticals
IONS
$9.35B
$880K 0.16%
21,881
+2,104
+11% +$94.5K
1 2
3
4 5

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, Virtus ETF Advisers held 194 positions worth $562M, up 68% from $335M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Virtus ETF Advisers deployed $212M of net new capital in Q1 2017, opening 19 new positions and adding to 129 existing holdings. Its largest new stake was Kinder Morgan: 272,117 shares worth $5.92M.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 57% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.3M trimmed.

  • Virtus ETF Advisers's largest Q1 2017 buy was Kinder Morgan: 272,117 shares worth $5.92M.
  • Virtus ETF Advisers added most to iShares 0-1 Year Treasury Bond ETF in Q1 2017, an estimated $22.2M increase.
  • Virtus ETF Advisers's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.3M.
  • Virtus ETF Advisers fully exited iShares Expanded Tech Sector ETF in Q1 2017, selling an estimated $2.47M.
  • Virtus ETF Advisers's ten largest holdings make up 52% of its $562M portfolio in Q1 2017.
  • Virtus ETF Advisers opened 19 new positions and closed 24 in Q1 2017.
  • Virtus ETF Advisers's portfolio value rose 68% quarter-over-quarter to $562M.

Based on Virtus ETF Advisers's 13F filing for Q1 2017, filed 15 May 2017.